A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder
- 1 April 1995
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 37 (7) , 462-466
- https://doi.org/10.1016/0006-3223(94)00190-e
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Enhanced Sensitivity to Cholecystokinin Tetrapeptide in Panic DisorderArchives of General Psychiatry, 1991
- Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic DisorderThe Canadian Journal of Psychiatry, 1990
- Cholecystokinin Tetrapeptide Induces Panic-like Attacks in Healthy VolunteersArchives of General Psychiatry, 1989
- Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter TrialArchives of General Psychiatry, 1988
- Two brain cholecystokinin receptors: implications for behavioral actionsBrain Research, 1986
- Neuronal Cholecystokinin: One or Multiple Transmitters?Journal of Neurochemistry, 1985
- Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neuronesNature, 1984
- Cholecystokinin-octapeptide fragments: Binding to brain cholecystokinin receptorsEuropean Journal of Pharmacology, 1984
- Demonstration of a putative receptor site for cholecystokinin in rat brainNeuropeptides, 1980
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959